OverviewChartNews

Rough Rice (ZR September 2025)/  ECBOT

4/21/2025 8:19:06 PM Chg. +0.020 Bid3:14:40 AM Ask2:47:54 AM Open High Low Previous Close
13.560USD +0.15% 13.500 13.685 13.550 13.560 13.535 13.540
GlobeNewswire 4/1 Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tis...
GlobeNewswire 4/1 ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
GlobeNewswire 3/31 Coherent to Showcase Innovative Products, Technologies and Thought Leadership at OFC 2025
GlobeNewswire 3/31 Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
GlobeNewswire 3/28 Coherent Announces General Availability of Industry-First 100G ZR QSFP28-DCO With High Optical Outpu...
GlobeNewswire 3/28 Coherent Announces General Availability of 800G ZR/ZR+ QSFP-DD Transceiver
GlobeNewswire 3/17 Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin Ame...
GlobeNewswire 3/11 Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips,...
GlobeNewswire 3/6 New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 ...
GlobeNewswire 2/28 Six Coherent Products Receive Awards From Lightwave + BTR Innovation Reviews for Excellence in Optic...
GlobeNewswire 2/26 FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
GlobeNewswire 2/5 Coherent Corp. Reports Second Quarter Fiscal 2025 Results
GlobeNewswire 8/27/2024 Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire 8/22/2024 Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Prior...
GlobeNewswire 8/21/2024 Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in...
GlobeNewswire 8/14/2024 Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR...
GlobeNewswire 8/9/2024 Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
GlobeNewswire 8/9/2024 Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
GlobeNewswire 7/18/2024 The 2025 Porsche Panamera Turbo S E-Hybrid and Panamera GTS
GlobeNewswire 7/18/2024 Q2 2024 Revenue and Business Highlights, Guidance Upgrade
GlobeNewswire 7/15/2024 New Panamera sets a class record time on the Nürburgring Nordschleife
Newsfile Corp 7/9/2024 Teako Mobilizes Field Crew to Copper-Cobalt-Zinc Projects Lomunda-Venna and Tydalen Utilizing Recent...
GlobeNewswire 7/9/2024 Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmace...
GlobeNewswire 6/25/2024 Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
GlobeNewswire 6/20/2024 Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024